Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest, since we must keep one eye on the firehose of news. Otherwise, we hope to catch up on our naps and stroll with the official mascot. And what about you? This may be a good time to engage in spring cleaning or you could reach out to someone feeling isolated. You might also want to help the economy by purchasing some new masks. Or simply take stock of the world. Well, whatever you do, have a sunny time. Be safe, and see you soon.

Novovax (NVAX) was awarded a contract by the Department of Defense for up to $60 million to support production of a Covid-19 vaccine that will be manufactured in the U.S. The news comes after the company failed to make the cut as one of the five vaccine finalists selected for the Operation Warp Speed project. The agreement includes a 2020 delivery of 10 million doses for DoD that could be used in Phase 2/3 clinical trials or under an Emergency Use Authorization if approved by the Food and Drug Administration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.